The Israeli-British biotech start-up CIITECH announced Tuesday that it will fund a research project in collaboration with the Hebrew University of Jerusalem exploring methods for treating asthma with medical cannabis.

The study focuses on researching the effects of the non-psychoactive cannabis compound CBD and identifying its potential inhibitory effect on allergic airway inflammation that causes asthma attacks.

“We know that CBD has anti-inflammatory properties and we’re looking forward to investigating whether this will be effective on treating asthma and related respiratory conditions,” said Mechoulam.